ClinicalTrials.govrestricted
Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT00966940. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 4